Sign in
4

Changes in Ownership

PRECISION BIOSCIENCES INC Filed Acc 0001209191-21-005870

President and CEO sold 9,697 shares at $13.37 ($129,649)

  • President and CEO acquired 21,515 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KANE MATTHEW R. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-26 Exercise or conversion : show line 1 in the form +21,515 $0.04 $861 1,863,708 D
2021-01-26 Sale : show line 2 in the form −9,697 $13.37 $129,649 1,854,011 D
Open-market sales · 9,697 sh · avg $13.37 · $129,649

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-01-26 Exercise or conversion : show line 3 in the form Employee Stock Option (Right to Buy) −21,515 $0.04 2021-05-17 21,515 258,168 D
Loading xslF345X03/doc4.xml…